Search for an orphan drug
Other search option(s)
Marketing authorisation with orphan designation - USA
- Tradename: KOSELUGO
- ATC code : -
- EU Number: -
- MA date : 10/04/2020
- MA holder: ASTRAZENECA PHARMACEUTICALS
Therapeutic indication
Treatment of pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN).
Diseases list
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.